Skip to main content

Table 3 Fatty acid composition (%) of plasma for the omega-3 supplementation (N-3 PUFA) and placebo groups

From: 21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo

 

N-3 PUFA

Placebo

 

Fatty acids

Pre

Post

Pre

Post

p

EPA (20:5 n-3)

0.41 ± 0.16

0.68 ± 0.27*

0.59 ± 0.34

0.49 ± 0.24

0.004

DPA (22:5 n-3)

0.29 ± 0.092

0.35 ± 0.091

0.31 ± 0.095

0.30 ± 0.055

0.087

DHA (22:6 n-3)

1.61 ± 0.32

1.81 ± 0.43

1.65 ± 0.45

1.56 ± 0.042

0.058

α-Linolenic (18:3 n-3)

0.39 ± 0.12

0.38 ± 0.18

0.41 ± 0.10

0.36 ± 0.11

0.53

Linoleic (18:2 n-6)

21.68 ± 2.85

21.01 ± 1.89

22.75 ± 3.67

21.93 ± 3.16

0.86

Arachidonic (20:4 n-6)

8.00 ± 2.07

7.43 ± 1.69

7.42 ± 1.93

7.03 ± 1.97

0.86

  1. *Significant group by time interaction. All values are mean ± SD percentages for the omega-3 supplementation group (N-3 PUFA) and placebo group (PLA). Pre, data collected prior to 21-days of supplementation. Post, data collect after 21-day of supplementation. Data are shown as mean ± SD